The Scripps Research Institute-医療機器分野:企業M&A・提携分析

◆英語タイトル:The Scripps Research Institute - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011235
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institute offers technology and scientific services such as antibody development and production, cell based screening, high performance computing, normal blood donor service and murine behavioral assessment, among others. It also offers undergraduate, graduate and postdoctoral programs. TSRI also organizes academic preparation and educational outreach programs. The institute operates through its research centers and institutes including Integrative Molecular Biosciences, Center for Metabolomics, Dorris Neuroscience Center, Molecular Screening Center, and others. TSRI is headquartered in La Jolla, California, the US.

The Scripps Research Institute – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
The Scripps Research Institute, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
The Scripps Research Institute, Medical Equipment Deals By Type, 2011 to YTD 2017 7
The Scripps Research Institute, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
The Scripps Research Institute, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
The Scripps Research Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
The Scripps Research Institute, Medical Equipment, Deal Details 11
Partnerships 11
Pfizer Enters into Licensing Agreement with Scripps Research Institute 11
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 12
Brooks Life Science Enters Into Licensing Agreement With The Scripps Research Institute 13
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 14
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 15
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 16
The Scripps Research Institute – Key Competitors 17
The Scripps Research Institute – Key Employees 18
The Scripps Research Institute – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Corporate Communications 21
Nov 30, 2017: The Scripps Research Institute welcomes renowned data scientist Amalio Telenti 21
Jun 01, 2016: TSRI Appoints Richard King as Chief Operating Officer 22
Product News 23
Oct 13, 2017: Scripps Florida Scientists Unveil ‘Roadmap’ to Aid Osteoporosis Treatment Development 23
Oct 11, 2017: TSRI Chemists Use Modified DNA Nucleotides to Create New Materials 24
Sep 28, 2017: TSRI Researchers Get a Lead on How to Detect Degenerative Neurological Diseases Sooner 26
Aug 23, 2017: TSRI Researchers Develop Assay to Help Identify New Pain Medication Candidates 27
Jun 01, 2017: Global Virus Network Center of Excellence TSRI Investigation Reveals First-Ever Image of Elusive Viral Protein 28
Feb 22, 2017: TSRI Researchers Find Standard Pacemakers and Defibrillators Safe for MRI Using a New Protocol 30
Aug 08, 2016: TSRI Scientists Pinpoint Ebola’s Weak Spots 32
May 19, 2016: New HIV-Mimicking Particles That Trigger Immune Response Could Advance AIDS Vaccine Design 34
Mar 15, 2016: TSRI Scientists Identify Molecular Markers of Kidney Transplant Rejection 35
Feb 19, 2016: TSRI and JCVI scientists find popular stem cell techniques safe 37
Feb 18, 2016: Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor 38
Feb 10, 2016: Scripps Florida Researchers Develop ‘LIGHTSABR’—A Cheap, Portable Drug-Discovery System 40
Jan 28, 2016: TSRI Study Reveals Workings of Mysterious ‘Relief Valve’ that Protects Cells from Swelling 42
Jan 25, 2016: Crouching Protein, Hidden Enzyme : The Scripps Research Institute 44
Other Significant Developments 46
Oct 25, 2017: New ResearchKit App from The Scripps Research Institute Looks at How Genetic Risk Influences Heart Health Decisions 46
Jul 21, 2016: The Scripps Research Institute Leverages Powerful End-to-End DDN Storage to Help Reveal Secrets to New Medical Treatments 47
Jul 06, 2016: TSRI Awarded $20 Million for First Year of Precision Medicine Initiative Cohort Program 48
May 04, 2016: Scripps Research Institute Spin-off iGenomX Launches with Transformational New Library Construction Technology for DNA Sequencing 50
Jan 27, 2016: Philanthropist Samuel Yin Provides $12.8 Million Gift for New Laboratories at The Scripps Research Institute 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
The Scripps Research Institute, Medical Equipment, Key Facts 2
The Scripps Research Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
The Scripps Research Institute, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
The Scripps Research Institute, Medical Equipment Deals By Type, 2011 to YTD 2017 7
The Scripps Research Institute, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
The Scripps Research Institute, Deals By Market, 2011 to YTD 2017 9
The Scripps Research Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Pfizer Enters into Licensing Agreement with Scripps Research Institute 11
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 12
Brooks Life Science Enters Into Licensing Agreement With The Scripps Research Institute 13
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 14
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 15
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 16
The Scripps Research Institute, Key Competitors 17
The Scripps Research Institute, Key Employees 18
The Scripps Research Institute, Other Locations 19
The Scripps Research Institute, Subsidiaries 19
The Scripps Research Institute, Joint Venture 20

★海外企業調査レポート[The Scripps Research Institute-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Glenmark Pharmaceuticals Ltd (GLENMARK):企業の財務・戦略的SWOT分析
    Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Sirona Biochem Corp (SBM):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agent …
  • Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析
    Summary Adverum Biotechnologies Inc (Adverum) formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-relat …
  • Allahabad Bank (ALBK):企業の財務・戦略的SWOT分析
    Allahabad Bank (ALBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務分析
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Freehold Royalties Ltd (FRU):企業の財務・戦略的SWOT分析
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. Its oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provides horizon …
  • Rutgers The State University of New Jersey-医療機器分野:企業M&A・提携分析
    Summary Rutgers The State University of New Jersey (Rutgers) is a research university that offers undergraduate and postgraduate programs, and research in the areas of health sciences. The university provides continuing education for professional and personal advancement. It offers courses in the ar …
  • Airbnb Inc:企業の戦略・SWOT・財務情報
    Airbnb Inc - Strategy, SWOT and Corporate Finance Report Summary Airbnb Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Campbell Soup Company (CPB):企業の財務・戦略的SWOT分析
    Campbell Soup Company (CPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Indigo Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services for pharmaceutical research and development, biotechnology sectors. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, …
  • Brighthouse Financial, Inc. (BHF):企業の財務・戦略的SWOT分析
    Brighthouse Financial, Inc. (BHF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Selcia Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Selcia Ltd (Selcia), formerly SCYNEXIS Europe Ltd is a contract research company that offers drug discovery services. The company operates through its divisions including selcia discovery - a drug discovery operation, incorporating proprietary fragment screening; and Selcia Radiolabeling - t …
  • Avarga Ltd:企業の戦略・SWOT・財務情報
    Avarga Ltd - Strategy, SWOT and Corporate Finance Report Summary Avarga Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Penumbra Inc (PEN):企業の財務・戦略的SWOT分析
    Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Qiagen Aarhus AS:企業の戦略的SWOT分析
    Qiagen Aarhus AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Falco SD Holdings Co Ltd (4671):企業の財務・戦略的SWOT分析
    Summary Falco SD Holdings Co Ltd (Falco), formerly Falco Biosystems Ltd is a clinical testing and dispensing pharmacy service provider. The company offers services such as genetic testing, clinical trials, medical information systems development, and food sanitation and environmental testing. It pro …
  • Nippon Yusen Kabushiki Kaisha (9101)-石油・ガス分野:企業M&A・提携分析
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company transporting crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes line trade, air carg …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆